Molecular diagnosis of the central nervous system (CNS) infections

Jordi Vila1, Jordi Bosch1, Carmen Muñoz-Almagro2

  • 1Department of Clinical Microbiology, Hospital Clinic, University of Barcelona, Barcelona, Spain; Institute of Global Health of Barcelona (ISGlobal), Barcelona, Spain; Spanish Network for Research in Infectious Diseases, REIPI, Instituto de Salud Carlos III, Madrid, Spain.

Insights

Rapid molecular diagnostic panels for meningoencephalitis offer a significant advantage over traditional methods. These multiplex tests quickly identify bacteria, viruses, and fungi, improving patient outcomes for central nervous system infections.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Molecular Diagnostics

Background:

  • Central nervous system (CNS) infections like meningitis and encephalitis are life-threatening emergencies.
  • Prompt pathogen identification is crucial for effective antimicrobial therapy and preventing mortality.
  • Current diagnostic methods (culture, antigen detection) have limitations in speed and accuracy.

Purpose of the Study:

  • To review the utility of rapid syndromic molecular arrays for diagnosing meningoencephalitis.
  • To discuss the advantages and disadvantages of multiplex PCR-based panels in clinical settings.

Main Methods:

  • Review of multiplex PCR-based diagnostic panels for meningoencephalitis.
  • Analysis of turnaround time and pathogen coverage (bacteria, viruses, fungi).

Main Results:

  • Multiplex PCR panels provide results in approximately 1 hour.
  • These panels cover a broad range of prevalent causative microorganisms.
  • Offers a significant improvement over conventional diagnostic techniques.

Conclusions:

  • Rapid molecular arrays represent a valuable advancement in diagnosing CNS infections.
  • Syndromic testing enhances timely and appropriate treatment decisions.
  • Further evaluation of these tools is warranted to optimize their clinical application.